StemExpress announces the release of G-CSF mobilized Leukopaks. Human mobilized Leukopaks provide a large quantity of mononuclear cells (MNCs) that contains a rich source of hematopoietic stem cells as compared to traditional leukopaks allowing researchers greater reproducibility of experiments from a single donor (minimize donor-to-donor variation), increase in scalability of experiments from a single product, and a decrease in same cell variability by obtaining high yields of specific cell types.
Human Mobilized Peripheral Blood Leukopaks are collected from healthy IRB consented donors that are negative for HIV, HBV and HCV from our own collection center. Mobilized peripheral blood donors are injected with Granulocyte-Colony Stimulating Factor (G-CSF), which stimulates the bone marrow to produce hematopoietic stem cells and mobilizes them into the bloodstream, over a period of 3–5 days. Mobilized mononuclear cells are collected by one of our trained technicians using the Spectra Optia® Apheresis System one or two days post injection (1 bag collected per day).